Latest news with #Diagnostics
Yahoo
4 days ago
- Automotive
- Yahoo
Eagers Automotive's (ASX:APE) Returns On Capital Are Heading Higher
To find a multi-bagger stock, what are the underlying trends we should look for in a business? Amongst other things, we'll want to see two things; firstly, a growing return on capital employed (ROCE) and secondly, an expansion in the company's amount of capital employed. This shows us that it's a compounding machine, able to continually reinvest its earnings back into the business and generate higher returns. So when we looked at Eagers Automotive (ASX:APE) and its trend of ROCE, we really liked what we saw. AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. For those that aren't sure what ROCE is, it measures the amount of pre-tax profits a company can generate from the capital employed in its business. The formula for this calculation on Eagers Automotive is: Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities) 0.18 = AU$538m ÷ (AU$5.5b - AU$2.4b) (Based on the trailing twelve months to December 2024). So, Eagers Automotive has an ROCE of 18%. In absolute terms, that's a pretty normal return, and it's somewhat close to the Specialty Retail industry average of 16%. View our latest analysis for Eagers Automotive In the above chart we have measured Eagers Automotive's prior ROCE against its prior performance, but the future is arguably more important. If you're interested, you can view the analysts predictions in our free analyst report for Eagers Automotive . Eagers Automotive is displaying some positive trends. The numbers show that in the last five years, the returns generated on capital employed have grown considerably to 18%. Basically the business is earning more per dollar of capital invested and in addition to that, 31% more capital is being employed now too. This can indicate that there's plenty of opportunities to invest capital internally and at ever higher rates, a combination that's common among multi-baggers. Another thing to note, Eagers Automotive has a high ratio of current liabilities to total assets of 44%. This can bring about some risks because the company is basically operating with a rather large reliance on its suppliers or other sorts of short-term creditors. Ideally we'd like to see this reduce as that would mean fewer obligations bearing risks. To sum it up, Eagers Automotive has proven it can reinvest in the business and generate higher returns on that capital employed, which is terrific. And a remarkable 199% total return over the last five years tells us that investors are expecting more good things to come in the future. Therefore, we think it would be worth your time to check if these trends are going to continue. On a final note, we found 3 warning signs for Eagers Automotive (1 is significant) you should be aware of. If you want to search for solid companies with great earnings, check out this free list of companies with good balance sheets and impressive returns on equity. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
4 days ago
- Automotive
- Yahoo
Eagers Automotive's (ASX:APE) Returns On Capital Are Heading Higher
To find a multi-bagger stock, what are the underlying trends we should look for in a business? Amongst other things, we'll want to see two things; firstly, a growing return on capital employed (ROCE) and secondly, an expansion in the company's amount of capital employed. This shows us that it's a compounding machine, able to continually reinvest its earnings back into the business and generate higher returns. So when we looked at Eagers Automotive (ASX:APE) and its trend of ROCE, we really liked what we saw. AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. For those that aren't sure what ROCE is, it measures the amount of pre-tax profits a company can generate from the capital employed in its business. The formula for this calculation on Eagers Automotive is: Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities) 0.18 = AU$538m ÷ (AU$5.5b - AU$2.4b) (Based on the trailing twelve months to December 2024). So, Eagers Automotive has an ROCE of 18%. In absolute terms, that's a pretty normal return, and it's somewhat close to the Specialty Retail industry average of 16%. View our latest analysis for Eagers Automotive In the above chart we have measured Eagers Automotive's prior ROCE against its prior performance, but the future is arguably more important. If you're interested, you can view the analysts predictions in our free analyst report for Eagers Automotive . Eagers Automotive is displaying some positive trends. The numbers show that in the last five years, the returns generated on capital employed have grown considerably to 18%. Basically the business is earning more per dollar of capital invested and in addition to that, 31% more capital is being employed now too. This can indicate that there's plenty of opportunities to invest capital internally and at ever higher rates, a combination that's common among multi-baggers. Another thing to note, Eagers Automotive has a high ratio of current liabilities to total assets of 44%. This can bring about some risks because the company is basically operating with a rather large reliance on its suppliers or other sorts of short-term creditors. Ideally we'd like to see this reduce as that would mean fewer obligations bearing risks. To sum it up, Eagers Automotive has proven it can reinvest in the business and generate higher returns on that capital employed, which is terrific. And a remarkable 199% total return over the last five years tells us that investors are expecting more good things to come in the future. Therefore, we think it would be worth your time to check if these trends are going to continue. On a final note, we found 3 warning signs for Eagers Automotive (1 is significant) you should be aware of. If you want to search for solid companies with great earnings, check out this free list of companies with good balance sheets and impressive returns on equity. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Edmunds
24-05-2025
- Automotive
- Edmunds
P0603: Internal Control Module Keep Alive Memory (KAM) Error
What does the P0603 error code mean? P0603 is a diagnostic trouble code that translates to "Internal Control Module Keep Alive Memory (KAM) Error." Specifically, it means the KAM — a part of the powertrain control module — has failed its self-test, which the powertrain control module runs periodically to make sure things are in good working order. Much like a computer's hard drive saves files even when the device is turned off, the KAM's job is to save or "keep alive" information that will be used the next time the vehicle is running. Why is this issue important? It's the KAM's job to save information about various systems, such as fuel delivery, timing and transmission control. This feedback is being constantly collected, allowing the powertrain control module to adaptively adjust to environmental factors, a person's driving style, and system wear as the vehicle is driven. If that data is no longer being stored or is inaccessible due to an issue with the KAM, the powertrain control module has to revert to default presets for these settings, which can vary widely from what has been learned, especially on older vehicles. Using those presets can result in rough idling, reduced fuel economy, or poor transmission performance, and it can cause unnecessary wear or damage if not fixed quickly. The code may be a symptom of an electrical issue, such as a failing battery, faulty wiring, or a malfunctioning powertrain control module. Can I safely drive my car with this error code? Until you know what's causing the P0603 error, it's best to drive the vehicle as little as possible. A KAM issue can cause erratic vehicle behavior, which may put you in an unsafe situation, and driving the vehicle using the original presets can lead to permanent issues if left unaddressed. The best course of action is to diagnose the issue with the vehicle as soon as possible before continuing to drive it regularly. Common symptoms of the P0603 error code The check engine light is illuminated. The engine idles roughly or hesitates when you press the accelerator pedal. Vehicle performance is sluggish, which may include slower-than-normal acceleration. You may notice increased fuel consumption. The engine is hard to start or won't start at all. The transmission may shift unexpectedly or fail to upshift or downshift when appropriate. The battery may drain, or there may be other electrical malfunctions. How is the P0603 error code diagnosed? Use an OBD-II scanner : Confirm the presence of the P0603 code and check for any related error codes before proceeding. It's possible that the P0603 error is being caused by another system problem. : Confirm the presence of the P0603 code and check for any related error codes before proceeding. It's possible that the P0603 error is being caused by another system problem. Inspect the battery and charging system : Inspect the battery for loose connections or corroded terminals and attend to them as necessary. Using a multimeter, check the battery's voltage — it should be above 12 volts when the vehicle is off or around 14 volts with the engine running. You can also check the alternator's output or take the vehicle to an auto parts store that offers free alternator testing. : Inspect the battery for loose connections or corroded terminals and attend to them as necessary. Using a multimeter, check the battery's voltage — it should be above 12 volts when the vehicle is off or around 14 volts with the engine running. You can also check the alternator's output or take the vehicle to an auto parts store that offers free alternator testing. Check the powertrain control module power supply : Inspect for loose connections, damaged wiring, or blown fuses on circuits that supply power to the powertrain control module. : Inspect for loose connections, damaged wiring, or blown fuses on circuits that supply power to the powertrain control module. Inspect powertrain control module ground connections : Make sure the powertrain control module is properly grounded by testing with a multimeter. Poor grounding can lead to all sorts of electrical issues and erratic behavior. : Make sure the powertrain control module is properly grounded by testing with a multimeter. Poor grounding can lead to all sorts of electrical issues and erratic behavior. Look for aftermarket modifications : If someone installed a performance tuning chip in the vehicle, it could be interfering with the powertrain control module's functioning. : If someone installed a performance tuning chip in the vehicle, it could be interfering with the powertrain control module's functioning. Test the powertrain control module: If no external issues are found, the powertrain control module itself may be faulty and require further testing, a reset or replacement. How is the P0603 error code repaired? Tighten the battery terminal connections and clean any corrosion from them. Replace a weak or failing battery to ensure consistent voltage to the powertrain control module. Repair or replace a faulty alternator if it is not supplying enough voltage to keep the battery charged. Repair or replace any damaged wiring, connectors, or fuses that supply power to the powertrain control module. Clean and secure the powertrain control module ground connections to ensure proper electrical function. Remove any aftermarket tuning devices or performance chips that may be interfering with the powertrain control module. If necessary, reprogram or replace the powertrain control module if it is found to be malfunctioning. After any repair attempt, use an OBD-II scanner to reset the error code and then conduct a test drive to verify the issue has been resolved. If the code does not return, the repair was successful. Related reading Follow the link below to reach our diagnostic check engine trouble codes catalog: On-board diagnostics (BD-II) trouble code directory
Scotsman
21-05-2025
- Health
- Scotsman
The silent killer: Breakthrough in pursuit of Johne's Disease diagnoses
For farmers across the UK, Johne's Disease represents an enormous challenge, costing an estimated £200 per cow per year, which can amount to 50% of a farmer's annual profit. However, a unique diagnostics approach from pioneering scientists at MI:RNA could transform the way a common livestock disease, which costs the UK agricultural economy £10 million annually, is managed. Sign up to our daily newsletter – Regular news stories and round-ups from around Scotland direct to your inbox Sign up Thank you for signing up! Did you know with a Digital Subscription to The Scotsman, you can get unlimited access to the website including our premium content, as well as benefiting from fewer ads, loyalty rewards and much more. Learn More Sorry, there seem to be some issues. Please try again later. Submitting... An inflammatory condition which primarily affects sheep and cattle, Johne's Disease spreads easily through herds impacting the health, welfare and productivity of livestock, with a prevalence of up to 50% within herds in the UK. The limitations of current diagnostic tests exacerbate the difficulty of managing Johne's disease, which often goes undiagnosed due to 'silent' carriers of the disease. Traditionally, screening and removal of animals affected by the disease was common practice to manage Johne's Disease. However, a new and promising approach for developing novel and reliable diagnostics will allow the disease to be identified earlier,reducing the number of cows lost to the disease, and paving the way for new treatments. Advertisement Hide Ad Advertisement Hide Ad MicroRNAs (miRNAs), which control the proteins that cells produce, are found in most eukaryotes (organisms with cells containing a nucleus) and play critical roles in gene regulation. From left to right - Dr Paul Capewell (Bioinformatics consultant), Dr Frank Turnbull (Lab Manager), Dr Robert Coultous (CSO), Marta Lis (Lab tech), Dr Eve Hanks (CEO). MicroRNAs are valuable biomarkers, which capture what happens in cells, due to their stability and ease of detection in fluids. Studies show that miRNA expression levels (the levels of gene activity) change during bacterial infections, including early-stage Mycobacterium avium subspecies paratuberculosis (MAP). Diagnostic accuracy, which is the ability to distinguish between healthy samples and samples with the disease, can be enhanced with advanced statistical and machine learning (AI) methods. These tools analyse data quickly, detect patterns missed by traditional methods, and provide predictions about infections. A preliminary study by MI:RNA Diagnostics and SRUC scientists investigated the use of miRNAs profiling for diagnosing Johne's disease by measuring miRNAs expression in samples from MAP-infected and uninfected cattle. The data was analysed using machine learning to develop an optimal method of disease diagnosis. The study found that miRNA profiling, along with advanced predictive modelling, has the potential to be utilised as a test for diagnosing Johne's disease in cattle. Due to the small sample size of the study, future efforts will increase the sample size to further validate findings and improve precision. There is also the possibility of differentiating between animals with alternative pathogens through MI:RNA Diagnostics methods. Advertisement Hide Ad Advertisement Hide Ad Eve Hanks, Founder and CEO at MI:RNA Diagnostics, said: 'Animal health is more important than ever, with Johne's disease costing farmers tens of millions around the UK each year. For MI:RNA this is a key area of research and development. Biomarker science combined with our AI-powered modelling, means that we can significantly improve animal health, reduce financial strain on farmers, while also reducing greenhouse gas output as a result. We believe miRNAs can assist with progressing future diagnostic testing and understanding diseases more effectively.'
Yahoo
14-05-2025
- Business
- Yahoo
Clinical Diagnostics Automation Research Business Report 2024-2030: Increasing Demand for High-throughput Testing Drives Clinical Diagnostics Automation Market Growth
The report delivers a detailed market analysis of the Global Clinical Diagnostics Automation Market, covering all major regions and market segments. It provides competitive insights by outlining the market presence of key players across various geographies. Additionally, it highlights future trends and drivers influencing the market's direction. The report also offers actionable insights to help identify new revenue opportunities and support strategic business decisions. Clinical Diagnostics Automation Market Dublin, May 14, 2025 (GLOBE NEWSWIRE) -- The "Clinical Diagnostics Automation - Global Strategic Business Report" report has been added to global market for Clinical Diagnostics Automation was valued at US$5.7 Billion in 2024 and is projected to reach US$8.3 Billion by 2030, growing at a CAGR of 6.5% over the analysis period 2024-2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The report includes the most recent global tariff developments and how they impact the Clinical Diagnostics Automation market. Computer-Aided Detection (CAD) systems, utilizing advanced algorithms and machine learning, play a crucial role in interpreting medical images and enhancing diagnostic accuracy across various medical fields. These systems assist radiologists by identifying potential abnormalities in images from X-rays, MRIs, endoscopies, and ultrasounds, providing vital diagnostic support. With the integration of sophisticated technologies such as artificial intelligence, CAD systems are becoming increasingly vital in fields like digital pathology, preventive screenings, and emergency diagnostics. The growing demand for these systems is driven by their ability to improve patient outcomes by supporting early detection and accurate diagnosis, particularly in complex areas such as advancements in medical imaging technologies such as mammography and MRI, coupled with the rising prevalence of cancer, are major drivers for the CAD market. These improvements lead to more precise and higher-resolution images, allowing CAD software to perform more accurate analyses. Additionally, the shift towards cloud computing in healthcare has enabled the development of scalable and accessible CAD solutions that offer reduced IT costs and enhanced collaboration among healthcare providers. The trend towards multi-modality CAD systems, capable of analyzing images from various diagnostic equipment, further enhances diagnostic accuracy and patient integration of AI in CAD systems marks a significant evolution in medical imaging, providing tools that learn from vast datasets to recognize complex patterns and anomalies indicative of diseases such as cancer. This AI integration speeds up diagnostics and reduces human error, aligning with the increasing emphasis on preventative healthcare and early diagnosis. Beyond general imaging, CAD systems find specialized applications in detecting conditions such as polyps in colonoscopy and lung nodules in pulmonology. Innovations in CAD are also making headways into digital pathology, with ongoing research expanding its applications beyond immunostaining to include broader diagnostic tasks such as analyzing standard H&E stains, highlighting its potential to significantly impact future medical practices. Tariff Impact Analysis: Key Insights for 2025Global tariff negotiations across 180+ countries are reshaping supply chains, costs, and competitiveness. This report reflects the latest developments as of April 2025 and incorporates forward-looking insights into the market analysts continuously track trade developments worldwide, drawing insights from leading global economists and over 200 industry and policy institutions, including think tanks, trade organizations, and national economic advisory bodies. This intelligence is integrated into forecasting models to provide timely, data-driven analysis of emerging risks and You Should Buy This Report: Detailed Market Analysis: Access a thorough analysis of the Global Clinical Diagnostics Automation Market, covering all major geographic regions and market segments. Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies. Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Clinical Diagnostics Automation Market. Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions. Report Features: Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030. In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa. Company Profiles: Coverage of players such as Abaxis Inc., Abbott Diagnostics, Beckman Coulter Inc., Becton Dickinson and Company, bioMerieux SA and more. Gain insights into the U.S. market, valued at $1.5 Billion in 2024, and China, forecasted to grow at an impressive 10.6% CAGR to reach $1.9 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific. Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments. What's Included in This Edition: Tariff-adjusted market forecasts by region and segment Analysis of cost and supply chain implications by sourcing and trade exposure Strategic insights into geographic shifts Buyers receive a free July 2025 update with: Finalized tariff impacts and new trade agreement effects Updated projections reflecting global sourcing and cost shifts Expanded country-specific coverage across the industry Key Attributes: Report Attribute Details No. of Pages 199 Forecast Period 2024 - 2030 Estimated Market Value (USD) in 2024 $5.7 Billion Forecasted Market Value (USD) by 2030 $8.3 Billion Compound Annual Growth Rate 6.5% Regions Covered Global Key Topics Covered: MARKET OVERVIEW Influencer Market Insights Tariff Impact on Global Supply Chain Patterns Global Economic Update Clinical Diagnostics Automation - Global Key Competitors Percentage Market Share in 2024 (E) Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E) Global Economic Update MARKET TRENDS & DRIVERS Rising Investments in Biotechnology - A Key Growth Driver Microplate instrumentation - An Integral Component of Lab Automation Market Modular Automation Surges Ahead of TLA in Adoption Automation in Immunohistochemistry offers High Throughput Capabilities Demand for Automated Hematology Analyzers on Rise Automated Multiplexing Technology and its Role in Clinical Diagnostics Automation Laboratory Information System - A Key Aspect of Clinical Diagnostics Automation Increasing Demand for High-throughput Testing Drives Clinical Diagnostics Automation Market Growth Growth in Molecular Diagnostics Strengthens Business Case for Automation Integration of AI and Robotics in Diagnostics Automation Throws Spotlight on Innovation Rising Investments in Healthcare Infrastructure Expands Market Horizons Development of Integrated Diagnostics Platforms Strengthens Market Position FOCUS ON SELECT PLAYERS:Some of the 54 companies featured in this Clinical Diagnostics Automation market report Abaxis Inc. Abbott Diagnostics Beckman Coulter Inc. Becton Dickinson and Company bioMerieux SA Bio-Rad Laboratories Inc. Diagnostica Stago Eppendorf AG HORIBA ABX SAS Hudson Robotics Inc. Ortho Clinical Diagnostics Inc. PerkinElmer Inc. QIAGEN NV Siemens Healthineers Sysmex America Inc. Tecan Group Ltd. Thermo Fischer Scientific Inc. For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment Clinical Diagnostics Automation Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Sign in to access your portfolio
